Enzymatically stable 5' mRNA cap analogs: synthesis and binding studies with human DcpS decapping enzyme

Area of Science:

• Biochemistry
• Molecular Biology
• Medicinal Chemistry

Background:

• The 5' mRNA cap is crucial for mRNA stability, translation, and cellular localization.
• Human decapping scavenger (DcpS) enzyme hydrolyzes uncapped or degraded mRNA, impacting mRNA turnover.
• Developing stable mRNA cap analogs is essential for various biological and therapeutic applications.

Purpose of the Study:

• To synthesize and characterize novel 5' mRNA cap analogs with enhanced stability and specific incorporation properties.
• To evaluate the resistance of these analogs to human DcpS enzyme-mediated degradation.
• To explore the potential applications of these analogs in biochemical research and drug discovery.

Main Methods:

• Synthesis of four novel 5' mRNA cap analogs by replacing a pyrophosphate bridge oxygen with a methylene group.
• Preparation involved reacting nucleoside phosphor/phosphon-1-imidazolidates with nucleoside phosphate/phosphonate using ZnCl2.
• Assessed resistance to human DcpS and binding affinity, as well as orientation during mRNA incorporation.

Main Results:

• Three novel cap analogs demonstrated complete resistance to human DcpS degradation.
• One analog exhibited very high binding affinity for human DcpS.
• Two analogs functioned as Anti Reverse Cap Analogs, ensuring correct mRNA chain orientation.

Conclusions:

• The synthesized mRNA cap analogs offer significant resistance to DcpS-mediated degradation.
• These analogs possess properties suitable for biochemical studies and understanding decapping enzyme function.
• The developed analogs serve as a foundation for potential anti-cancer and anti-parasite drug development.